Completion of Enrollment in 1st US Clinical Trial & Achievement of 1st Primary Objective
JERUSALEM, Oct. 25, 2021 -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha...
Completion of Enrollment in 1st US Clinical Trial & Achievement of 1st Primary Objective
Meet Alpha Tau at ASTRO Chicago 2021
Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM